1.Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016). Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertility and Sterility, 105(1), 3-15.
2.Barrionuevo, P., Nabhan, M., Altayar, O., Wang, Z., Erwin, P. J., Asi, N., Martin, K. A., & Murad, M. H. (2018). Treatments for hirsutism in women with polycystic ovary syndrome: A systematic review and network meta-analysis of randomized controlled trials. Journal of Clinical Endocrinology & Metabolism, 103(4), 1258-1267.
3.Hammes, B., & Raulin, C. (2005). Laser hair removal in hirsute women with polycystic ovary syndrome: A randomized controlled trial. British Journal of Dermatology, 152(5), 986-992.
4.Wolf, J. E., Shander, D., Huber, F., Jackson, J., Lin, C. S., Matheson, R. T., & Schrode, K. (2004). Eflornithine cream (Vaniqa) for facial hirsutism in polycystic ovary syndrome: Results of a randomized, double-blind, placebo-controlled trial. Journal of Drugs in Dermatology, 3(5), 512-517.
5.Grant, P. (2010). Spearmint herbal tea has significant anti-androgen effects in polycystic ovary syndrome: A randomized controlled trial. Phytotherapy Research, 24(2), 186-188.
6.Zeichner, J. A. (2016). Ingrown hair prevention in hirsutism: A dermatologist's perspective. Journal of Cosmetic Dermatology, 15(3), 274-278.
7.U.S. Food and Drug Administration. (2020). Permanent hair removal options: Electrolysis vs. laser.
8.American Academy of Dermatology. (2022). Post-laser care for skin of color.
9.PCOS Awareness Association. (n.d.). Hirsutism management resources.
10.Hormone Health Network. (n.d.). PCOS and hair removal FAQs.